nodes	percent_of_prediction	percent_of_DWPC	metapath
Saxagliptin—ABCC1—Vemurafenib—skin cancer	0.265	0.329	CbGbCtD
Saxagliptin—ABCC1—Dactinomycin—skin cancer	0.176	0.219	CbGbCtD
Saxagliptin—ABCC1—Docetaxel—skin cancer	0.0909	0.113	CbGbCtD
Saxagliptin—CYP3A4—Temozolomide—skin cancer	0.0699	0.0868	CbGbCtD
Saxagliptin—CYP3A4—Imiquimod—skin cancer	0.0699	0.0868	CbGbCtD
Saxagliptin—CYP3A4—Vismodegib—skin cancer	0.0485	0.0602	CbGbCtD
Saxagliptin—CYP3A4—Vemurafenib—skin cancer	0.0383	0.0476	CbGbCtD
Saxagliptin—CYP3A5—Docetaxel—skin cancer	0.0337	0.0419	CbGbCtD
Saxagliptin—Idiopathic thrombocytopenic purpura—Imiquimod—skin cancer	0.015	0.0942	CcSEcCtD
Saxagliptin—CYP3A4—Docetaxel—skin cancer	0.0131	0.0163	CbGbCtD
Saxagliptin—DPP8—nipple—skin cancer	0.00555	0.158	CbGeAlD
Saxagliptin—Opportunistic infection—Temozolomide—skin cancer	0.00388	0.0243	CcSEcCtD
Saxagliptin—SLCO4C1—nipple—skin cancer	0.00351	0.1	CbGeAlD
Saxagliptin—DPP8—mammalian vulva—skin cancer	0.00324	0.0925	CbGeAlD
Saxagliptin—DPP4—blood vessel—skin cancer	0.00322	0.092	CbGeAlD
Saxagliptin—Lymphopenia—Temozolomide—skin cancer	0.00305	0.0191	CcSEcCtD
Saxagliptin—Malnutrition—Vismodegib—skin cancer	0.00216	0.0136	CcSEcCtD
Saxagliptin—SLCO4C1—mammalian vulva—skin cancer	0.00205	0.0585	CbGeAlD
Saxagliptin—Lymphopenia—Docetaxel—skin cancer	0.00203	0.0127	CcSEcCtD
Saxagliptin—Purpura—Imiquimod—skin cancer	0.00196	0.0123	CcSEcCtD
Saxagliptin—ABCC1—hair follicle—skin cancer	0.00194	0.0555	CbGeAlD
Saxagliptin—Myalgia—Vismodegib—skin cancer	0.00184	0.0115	CcSEcCtD
Saxagliptin—Arthralgia—Vismodegib—skin cancer	0.00184	0.0115	CcSEcCtD
Saxagliptin—Unspecified disorder of skin and subcutaneous tissue—Vismodegib—skin cancer	0.00183	0.0115	CcSEcCtD
Saxagliptin—Face oedema—Imiquimod—skin cancer	0.00183	0.0114	CcSEcCtD
Saxagliptin—DPP9—lymph node—skin cancer	0.00178	0.0509	CbGeAlD
Saxagliptin—Skin disorder—Vismodegib—skin cancer	0.00171	0.0107	CcSEcCtD
Saxagliptin—Infestation—Vemurafenib—skin cancer	0.00171	0.0107	CcSEcCtD
Saxagliptin—Infestation NOS—Vemurafenib—skin cancer	0.00171	0.0107	CcSEcCtD
Saxagliptin—DPP4—connective tissue—skin cancer	0.00165	0.0472	CbGeAlD
Saxagliptin—DPP8—lymph node—skin cancer	0.00162	0.0463	CbGeAlD
Saxagliptin—Musculoskeletal discomfort—Vismodegib—skin cancer	0.00161	0.0101	CcSEcCtD
Saxagliptin—DPP4—epithelium—skin cancer	0.00157	0.0448	CbGeAlD
Saxagliptin—Dyspepsia—Vismodegib—skin cancer	0.00155	0.00973	CcSEcCtD
Saxagliptin—Gastrointestinal disorder—Vismodegib—skin cancer	0.00152	0.00955	CcSEcCtD
Saxagliptin—Fatigue—Vismodegib—skin cancer	0.00152	0.00953	CcSEcCtD
Saxagliptin—Upper respiratory tract infection—Imiquimod—skin cancer	0.00152	0.00952	CcSEcCtD
Saxagliptin—Oedema peripheral—Vemurafenib—skin cancer	0.00151	0.00947	CcSEcCtD
Saxagliptin—Erectile dysfunction—Imiquimod—skin cancer	0.00151	0.00944	CcSEcCtD
Saxagliptin—Infestation NOS—Imiquimod—skin cancer	0.00146	0.00914	CcSEcCtD
Saxagliptin—Infestation—Imiquimod—skin cancer	0.00146	0.00914	CcSEcCtD
Saxagliptin—Gastrointestinal pain—Vismodegib—skin cancer	0.00144	0.00904	CcSEcCtD
Saxagliptin—Urinary tract infection—Imiquimod—skin cancer	0.00142	0.00888	CcSEcCtD
Saxagliptin—Abdominal pain—Vismodegib—skin cancer	0.00139	0.00874	CcSEcCtD
Saxagliptin—Sinusitis—Imiquimod—skin cancer	0.00137	0.00857	CcSEcCtD
Saxagliptin—DPP4—mammalian vulva—skin cancer	0.00136	0.0389	CbGeAlD
Saxagliptin—Malnutrition—Vemurafenib—skin cancer	0.00134	0.00837	CcSEcCtD
Saxagliptin—ABCC1—nipple—skin cancer	0.00132	0.0376	CbGeAlD
Saxagliptin—Gastroenteritis—Temozolomide—skin cancer	0.00128	0.00802	CcSEcCtD
Saxagliptin—Asthenia—Vismodegib—skin cancer	0.00127	0.00793	CcSEcCtD
Saxagliptin—Pruritus—Vismodegib—skin cancer	0.00125	0.00782	CcSEcCtD
Saxagliptin—DPP4—lymphoid tissue—skin cancer	0.00121	0.0345	CbGeAlD
Saxagliptin—Immune system disorder—Imiquimod—skin cancer	0.00118	0.00741	CcSEcCtD
Saxagliptin—Purpura—Temozolomide—skin cancer	0.00118	0.00737	CcSEcCtD
Saxagliptin—DPP4—female reproductive system—skin cancer	0.00117	0.0333	CbGeAlD
Saxagliptin—Malnutrition—Imiquimod—skin cancer	0.00114	0.00714	CcSEcCtD
Saxagliptin—Arthralgia—Vemurafenib—skin cancer	0.00114	0.00713	CcSEcCtD
Saxagliptin—Myalgia—Vemurafenib—skin cancer	0.00114	0.00713	CcSEcCtD
Saxagliptin—Unspecified disorder of skin and subcutaneous tissue—Vemurafenib—skin cancer	0.00113	0.00708	CcSEcCtD
Saxagliptin—Vomiting—Vismodegib—skin cancer	0.00112	0.00703	CcSEcCtD
Saxagliptin—Rash—Vismodegib—skin cancer	0.00111	0.00697	CcSEcCtD
Saxagliptin—Dermatitis—Vismodegib—skin cancer	0.00111	0.00697	CcSEcCtD
Saxagliptin—Face oedema—Temozolomide—skin cancer	0.00109	0.00686	CcSEcCtD
Saxagliptin—Anaphylactic shock—Vemurafenib—skin cancer	0.00109	0.00683	CcSEcCtD
Saxagliptin—Infection—Vemurafenib—skin cancer	0.00108	0.00679	CcSEcCtD
Saxagliptin—Skin disorder—Vemurafenib—skin cancer	0.00106	0.00664	CcSEcCtD
Saxagliptin—Nausea—Vismodegib—skin cancer	0.00105	0.00657	CcSEcCtD
Saxagliptin—Angioedema—Imiquimod—skin cancer	0.00104	0.00652	CcSEcCtD
Saxagliptin—Musculoskeletal discomfort—Vemurafenib—skin cancer	0.000993	0.00622	CcSEcCtD
Saxagliptin—DPP4—head—skin cancer	0.000974	0.0278	CbGeAlD
Saxagliptin—Arthralgia—Imiquimod—skin cancer	0.00097	0.00608	CcSEcCtD
Saxagliptin—Myalgia—Imiquimod—skin cancer	0.00097	0.00608	CcSEcCtD
Saxagliptin—Unspecified disorder of skin and subcutaneous tissue—Imiquimod—skin cancer	0.000963	0.00604	CcSEcCtD
Saxagliptin—Gastrointestinal disorder—Vemurafenib—skin cancer	0.000941	0.0059	CcSEcCtD
Saxagliptin—Fatigue—Vemurafenib—skin cancer	0.00094	0.00589	CcSEcCtD
Saxagliptin—Nasopharyngitis—Fluorouracil—skin cancer	0.000934	0.00585	CcSEcCtD
Saxagliptin—Infection—Imiquimod—skin cancer	0.000923	0.00579	CcSEcCtD
Saxagliptin—Upper respiratory tract infection—Temozolomide—skin cancer	0.00091	0.00571	CcSEcCtD
Saxagliptin—Skin disorder—Imiquimod—skin cancer	0.000903	0.00566	CcSEcCtD
Saxagliptin—Erectile dysfunction—Temozolomide—skin cancer	0.000902	0.00566	CcSEcCtD
Saxagliptin—Infestation—Temozolomide—skin cancer	0.000873	0.00547	CcSEcCtD
Saxagliptin—Infestation NOS—Temozolomide—skin cancer	0.000873	0.00547	CcSEcCtD
Saxagliptin—Urinary tract infection—Temozolomide—skin cancer	0.000849	0.00532	CcSEcCtD
Saxagliptin—Musculoskeletal discomfort—Imiquimod—skin cancer	0.000847	0.00531	CcSEcCtD
Saxagliptin—Upper respiratory tract infection—Fluorouracil—skin cancer	0.000839	0.00526	CcSEcCtD
Saxagliptin—Sinusitis—Temozolomide—skin cancer	0.000819	0.00514	CcSEcCtD
Saxagliptin—Dyspepsia—Imiquimod—skin cancer	0.000818	0.00513	CcSEcCtD
Saxagliptin—Infestation—Fluorouracil—skin cancer	0.000805	0.00504	CcSEcCtD
Saxagliptin—Infestation NOS—Fluorouracil—skin cancer	0.000805	0.00504	CcSEcCtD
Saxagliptin—Hypersensitivity—Vemurafenib—skin cancer	0.000803	0.00503	CcSEcCtD
Saxagliptin—Gastrointestinal disorder—Imiquimod—skin cancer	0.000802	0.00503	CcSEcCtD
Saxagliptin—Fatigue—Imiquimod—skin cancer	0.000801	0.00502	CcSEcCtD
Saxagliptin—Urinary tract infection—Fluorouracil—skin cancer	0.000782	0.0049	CcSEcCtD
Saxagliptin—Asthenia—Vemurafenib—skin cancer	0.000782	0.0049	CcSEcCtD
Saxagliptin—Oedema peripheral—Temozolomide—skin cancer	0.000772	0.00484	CcSEcCtD
Saxagliptin—Pruritus—Vemurafenib—skin cancer	0.000771	0.00483	CcSEcCtD
Saxagliptin—ABCC1—mammalian vulva—skin cancer	0.000769	0.022	CbGeAlD
Saxagliptin—Gastrointestinal pain—Imiquimod—skin cancer	0.00076	0.00476	CcSEcCtD
Saxagliptin—Sinusitis—Fluorouracil—skin cancer	0.000755	0.00473	CcSEcCtD
Saxagliptin—Urticaria—Imiquimod—skin cancer	0.000738	0.00463	CcSEcCtD
Saxagliptin—Abdominal pain—Imiquimod—skin cancer	0.000735	0.00461	CcSEcCtD
Saxagliptin—Dizziness—Vemurafenib—skin cancer	0.000721	0.00452	CcSEcCtD
Saxagliptin—Immune system disorder—Temozolomide—skin cancer	0.000708	0.00444	CcSEcCtD
Saxagliptin—Vomiting—Vemurafenib—skin cancer	0.000693	0.00434	CcSEcCtD
Saxagliptin—Myalgia—Bleomycin—skin cancer	0.000689	0.00432	CcSEcCtD
Saxagliptin—Rash—Vemurafenib—skin cancer	0.000687	0.00431	CcSEcCtD
Saxagliptin—Dermatitis—Vemurafenib—skin cancer	0.000687	0.0043	CcSEcCtD
Saxagliptin—Hypersensitivity—Imiquimod—skin cancer	0.000685	0.00429	CcSEcCtD
Saxagliptin—Headache—Vemurafenib—skin cancer	0.000683	0.00428	CcSEcCtD
Saxagliptin—Malnutrition—Temozolomide—skin cancer	0.000683	0.00428	CcSEcCtD
Saxagliptin—DPP4—lymph node—skin cancer	0.000682	0.0195	CbGeAlD
Saxagliptin—Nasopharyngitis—Docetaxel—skin cancer	0.000674	0.00422	CcSEcCtD
Saxagliptin—Asthenia—Imiquimod—skin cancer	0.000667	0.00418	CcSEcCtD
Saxagliptin—Anaphylactic shock—Bleomycin—skin cancer	0.00066	0.00414	CcSEcCtD
Saxagliptin—Pruritus—Imiquimod—skin cancer	0.000658	0.00412	CcSEcCtD
Saxagliptin—Infection—Bleomycin—skin cancer	0.000656	0.00411	CcSEcCtD
Saxagliptin—Nausea—Vemurafenib—skin cancer	0.000647	0.00406	CcSEcCtD
Saxagliptin—Thrombocytopenia—Bleomycin—skin cancer	0.000647	0.00405	CcSEcCtD
Saxagliptin—Myalgia—Dactinomycin—skin cancer	0.000642	0.00403	CcSEcCtD
Saxagliptin—SLC22A8—head—skin cancer	0.00064	0.0183	CbGeAlD
Saxagliptin—Angioedema—Temozolomide—skin cancer	0.000624	0.00391	CcSEcCtD
Saxagliptin—Dizziness—Imiquimod—skin cancer	0.000615	0.00385	CcSEcCtD
Saxagliptin—Infection—Dactinomycin—skin cancer	0.000612	0.00384	CcSEcCtD
Saxagliptin—Thrombocytopenia—Dactinomycin—skin cancer	0.000603	0.00378	CcSEcCtD
Saxagliptin—Musculoskeletal discomfort—Bleomycin—skin cancer	0.000602	0.00377	CcSEcCtD
Saxagliptin—Vomiting—Imiquimod—skin cancer	0.000591	0.0037	CcSEcCtD
Saxagliptin—Rash—Imiquimod—skin cancer	0.000586	0.00367	CcSEcCtD
Saxagliptin—Dermatitis—Imiquimod—skin cancer	0.000586	0.00367	CcSEcCtD
Saxagliptin—Headache—Imiquimod—skin cancer	0.000582	0.00365	CcSEcCtD
Saxagliptin—Myalgia—Temozolomide—skin cancer	0.000581	0.00364	CcSEcCtD
Saxagliptin—Arthralgia—Temozolomide—skin cancer	0.000581	0.00364	CcSEcCtD
Saxagliptin—Infestation NOS—Docetaxel—skin cancer	0.000581	0.00364	CcSEcCtD
Saxagliptin—Infestation—Docetaxel—skin cancer	0.000581	0.00364	CcSEcCtD
Saxagliptin—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—skin cancer	0.000577	0.00362	CcSEcCtD
Saxagliptin—Musculoskeletal discomfort—Dactinomycin—skin cancer	0.000561	0.00352	CcSEcCtD
Saxagliptin—Anaphylactic shock—Temozolomide—skin cancer	0.000557	0.00349	CcSEcCtD
Saxagliptin—Infection—Temozolomide—skin cancer	0.000553	0.00347	CcSEcCtD
Saxagliptin—Nausea—Imiquimod—skin cancer	0.000552	0.00346	CcSEcCtD
Saxagliptin—Thrombocytopenia—Temozolomide—skin cancer	0.000545	0.00342	CcSEcCtD
Saxagliptin—Skin disorder—Temozolomide—skin cancer	0.000541	0.00339	CcSEcCtD
Saxagliptin—Myalgia—Fluorouracil—skin cancer	0.000535	0.00336	CcSEcCtD
Saxagliptin—Fatigue—Dactinomycin—skin cancer	0.000531	0.00333	CcSEcCtD
Saxagliptin—Urticaria—Bleomycin—skin cancer	0.000525	0.00329	CcSEcCtD
Saxagliptin—Oedema peripheral—Docetaxel—skin cancer	0.000514	0.00322	CcSEcCtD
Saxagliptin—Anaphylactic shock—Fluorouracil—skin cancer	0.000513	0.00322	CcSEcCtD
Saxagliptin—Infection—Fluorouracil—skin cancer	0.00051	0.0032	CcSEcCtD
Saxagliptin—Musculoskeletal discomfort—Temozolomide—skin cancer	0.000508	0.00318	CcSEcCtD
Saxagliptin—Gastrointestinal pain—Dactinomycin—skin cancer	0.000504	0.00316	CcSEcCtD
Saxagliptin—Thrombocytopenia—Fluorouracil—skin cancer	0.000503	0.00315	CcSEcCtD
Saxagliptin—Dyspepsia—Temozolomide—skin cancer	0.00049	0.00307	CcSEcCtD
Saxagliptin—Abdominal pain—Dactinomycin—skin cancer	0.000487	0.00305	CcSEcCtD
Saxagliptin—Hypersensitivity—Bleomycin—skin cancer	0.000487	0.00305	CcSEcCtD
Saxagliptin—Gastrointestinal disorder—Temozolomide—skin cancer	0.000481	0.00301	CcSEcCtD
Saxagliptin—Fatigue—Temozolomide—skin cancer	0.00048	0.00301	CcSEcCtD
Saxagliptin—Asthenia—Bleomycin—skin cancer	0.000474	0.00297	CcSEcCtD
Saxagliptin—Immune system disorder—Docetaxel—skin cancer	0.000471	0.00295	CcSEcCtD
Saxagliptin—Musculoskeletal discomfort—Fluorouracil—skin cancer	0.000468	0.00293	CcSEcCtD
Saxagliptin—Pruritus—Bleomycin—skin cancer	0.000467	0.00293	CcSEcCtD
Saxagliptin—Gastrointestinal pain—Temozolomide—skin cancer	0.000455	0.00286	CcSEcCtD
Saxagliptin—Malnutrition—Docetaxel—skin cancer	0.000454	0.00285	CcSEcCtD
Saxagliptin—Hypersensitivity—Dactinomycin—skin cancer	0.000454	0.00284	CcSEcCtD
Saxagliptin—Dyspepsia—Fluorouracil—skin cancer	0.000452	0.00283	CcSEcCtD
Saxagliptin—Gastrointestinal disorder—Fluorouracil—skin cancer	0.000443	0.00278	CcSEcCtD
Saxagliptin—Urticaria—Temozolomide—skin cancer	0.000443	0.00277	CcSEcCtD
Saxagliptin—Asthenia—Dactinomycin—skin cancer	0.000442	0.00277	CcSEcCtD
Saxagliptin—Abdominal pain—Temozolomide—skin cancer	0.00044	0.00276	CcSEcCtD
Saxagliptin—Vomiting—Bleomycin—skin cancer	0.00042	0.00263	CcSEcCtD
Saxagliptin—Rash—Bleomycin—skin cancer	0.000416	0.00261	CcSEcCtD
Saxagliptin—Dermatitis—Bleomycin—skin cancer	0.000416	0.00261	CcSEcCtD
Saxagliptin—Hypersensitivity—Temozolomide—skin cancer	0.00041	0.00257	CcSEcCtD
Saxagliptin—Urticaria—Fluorouracil—skin cancer	0.000408	0.00256	CcSEcCtD
Saxagliptin—Asthenia—Temozolomide—skin cancer	0.0004	0.00251	CcSEcCtD
Saxagliptin—Pruritus—Temozolomide—skin cancer	0.000394	0.00247	CcSEcCtD
Saxagliptin—Nausea—Bleomycin—skin cancer	0.000392	0.00246	CcSEcCtD
Saxagliptin—Vomiting—Dactinomycin—skin cancer	0.000392	0.00245	CcSEcCtD
Saxagliptin—Rash—Dactinomycin—skin cancer	0.000388	0.00243	CcSEcCtD
Saxagliptin—Myalgia—Docetaxel—skin cancer	0.000386	0.00242	CcSEcCtD
Saxagliptin—Arthralgia—Docetaxel—skin cancer	0.000386	0.00242	CcSEcCtD
Saxagliptin—ABCC1—lymph node—skin cancer	0.000385	0.011	CbGeAlD
Saxagliptin—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—skin cancer	0.000384	0.00241	CcSEcCtD
Saxagliptin—CYP3A4—female reproductive system—skin cancer	0.00038	0.0109	CbGeAlD
Saxagliptin—Hypersensitivity—Fluorouracil—skin cancer	0.000378	0.00237	CcSEcCtD
Saxagliptin—Anaphylactic shock—Docetaxel—skin cancer	0.00037	0.00232	CcSEcCtD
Saxagliptin—Dizziness—Temozolomide—skin cancer	0.000368	0.00231	CcSEcCtD
Saxagliptin—Infection—Docetaxel—skin cancer	0.000368	0.00231	CcSEcCtD
Saxagliptin—Nausea—Dactinomycin—skin cancer	0.000366	0.00229	CcSEcCtD
Saxagliptin—Pruritus—Fluorouracil—skin cancer	0.000363	0.00228	CcSEcCtD
Saxagliptin—Thrombocytopenia—Docetaxel—skin cancer	0.000363	0.00227	CcSEcCtD
Saxagliptin—Skin disorder—Docetaxel—skin cancer	0.00036	0.00226	CcSEcCtD
Saxagliptin—Vomiting—Temozolomide—skin cancer	0.000354	0.00222	CcSEcCtD
Saxagliptin—Rash—Temozolomide—skin cancer	0.000351	0.0022	CcSEcCtD
Saxagliptin—Dermatitis—Temozolomide—skin cancer	0.000351	0.0022	CcSEcCtD
Saxagliptin—Headache—Temozolomide—skin cancer	0.000349	0.00219	CcSEcCtD
Saxagliptin—Dizziness—Fluorouracil—skin cancer	0.000339	0.00213	CcSEcCtD
Saxagliptin—Musculoskeletal discomfort—Docetaxel—skin cancer	0.000337	0.00212	CcSEcCtD
Saxagliptin—Nausea—Temozolomide—skin cancer	0.000331	0.00207	CcSEcCtD
Saxagliptin—Vomiting—Fluorouracil—skin cancer	0.000326	0.00205	CcSEcCtD
Saxagliptin—Dyspepsia—Docetaxel—skin cancer	0.000326	0.00204	CcSEcCtD
Saxagliptin—Rash—Fluorouracil—skin cancer	0.000324	0.00203	CcSEcCtD
Saxagliptin—Dermatitis—Fluorouracil—skin cancer	0.000323	0.00203	CcSEcCtD
Saxagliptin—Headache—Fluorouracil—skin cancer	0.000322	0.00202	CcSEcCtD
Saxagliptin—Gastrointestinal disorder—Docetaxel—skin cancer	0.00032	0.002	CcSEcCtD
Saxagliptin—Fatigue—Docetaxel—skin cancer	0.000319	0.002	CcSEcCtD
Saxagliptin—Nausea—Fluorouracil—skin cancer	0.000305	0.00191	CcSEcCtD
Saxagliptin—Gastrointestinal pain—Docetaxel—skin cancer	0.000303	0.0019	CcSEcCtD
Saxagliptin—Abdominal pain—Docetaxel—skin cancer	0.000293	0.00184	CcSEcCtD
Saxagliptin—Hypersensitivity—Docetaxel—skin cancer	0.000273	0.00171	CcSEcCtD
Saxagliptin—Asthenia—Docetaxel—skin cancer	0.000266	0.00167	CcSEcCtD
Saxagliptin—Pruritus—Docetaxel—skin cancer	0.000262	0.00164	CcSEcCtD
Saxagliptin—Dizziness—Docetaxel—skin cancer	0.000245	0.00154	CcSEcCtD
Saxagliptin—Vomiting—Docetaxel—skin cancer	0.000236	0.00148	CcSEcCtD
Saxagliptin—Rash—Docetaxel—skin cancer	0.000234	0.00146	CcSEcCtD
Saxagliptin—Dermatitis—Docetaxel—skin cancer	0.000233	0.00146	CcSEcCtD
Saxagliptin—Headache—Docetaxel—skin cancer	0.000232	0.00145	CcSEcCtD
Saxagliptin—Nausea—Docetaxel—skin cancer	0.00022	0.00138	CcSEcCtD
